Dr Reddy's launches generic hypotensive injection in USDrug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of b...
Dr Reddy's loses patent case with Eli Lilly over AlimtaThe U.S. District Court for the Southern District of Indiana ruled in favor of Lilly, a release from the US drug maker said.
Pfizer Inc recalls 1.8 million vials of antibiotics"Piperacillin and tazobactam have been found to contain elevated levels of impurities that may result in decreased potency," a notification...
CCI clears Micromax-Madison India deal, 3 others get go-aheadIn a tweet, the watchdog said it has approved "acquisition of equity stake in Micromax Informatics Limited by Madison India Opportunities T...
Jubilant Life gets nod for Sodium Chloride injection“This is the first ANDA approval in injectables received by the company. We have filed two injectables and one ophthalmic product as on Mar...
Aurobindo gets final USFDA nod for pre-surgery sedation drugAurobindo Pharma has received final approval from the USFDA to manufacture and market pre- surgery sedation injections Dexmedetomidine Hydr...
Sun Pharma against use of its drug for lethal injection in USAccording to a media report, the Arkansas purchased three drugs, including one of Sun Pharma, which were enough to perform eight executions.
Pfizer shares gain over 3% as parent plans to buy HospiraShares of Pfizer rose by over 3 per cent as pharmaceuticals giant Pfizer Inc will acquire Hospira Inc, a leading provider of injectable dru...
Pfizer rallies over 6% on acquisition plans; scales above Rs 2000As per the report, Pfizer offered $90 per share in cash, a 39 percent premium to Hospira's closing stock price on Wednesday
Pfizer buying Hospira for about $15 billionThe deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.
Pfizer buying Hospira for about $15.23 billionPfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.
- Orchid Chemicals gets CCI nod for Hospira deal
Competition Commission of India today said it has approved a proposed sale by Orchid Chemicals and Pharmaceuticals Ltd (OCPL) of its certai...
- Orchid Chemicals up over 5%
Orchid Chem gained after it plans to sell various assets including active pharmaceutical ingredients biz and one R&D facility to the US-bas...
- US based Hospira to buy Orchid's API manufacturing, R&D units in $200 million deal
Orchid Chemicals today said it will sell various assets including active pharmaceutical ingredients (API) business and a R&D facility to Ho...
- Govt limits MNCs' supply of essential drugs on local buy
Foreign drug makers buying stake in Indian pharmaceutical companies will now be required to manufacture and supply essential medicines to t...
- Stocks to watch: Hero Honda, ITC, Tata Motors, Orchid Chemicals, Cholamandalam DBS Finance
Hero Honda declared its highest dividend yet on Tuesday, and held out the possibility of another payout next month, part of the company’s p...
- Dabur Pharma sets arm in US to tap oncology mkt
Dabur Pharma on Wednesday said it has set up a subsidiary company in the US, which will be directly responsible for sales, marketing and di...